These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 33753107

  • 1. Effect of dual PPAR-α/γ agonist saroglitazar on diabetic retinopathy and oxygen-induced retinopathy.
    Joharapurkar A, Patel V, Kshirsagar S, Patel MS, Savsani H, Jain M.
    Eur J Pharmacol; 2021 May 15; 899():174032. PubMed ID: 33753107
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Structural Basis for Anti-non-alcoholic Fatty Liver Disease and Diabetic Dyslipidemia Drug Saroglitazar as a PPAR α/γ Dual Agonist.
    Honda A, Kamata S, Satta C, Machida Y, Uchii K, Terasawa K, Nemoto A, Oyama T, Ishii I.
    Biol Pharm Bull; 2021 May 15; 44(9):1210-1219. PubMed ID: 34471049
    [Abstract] [Full Text] [Related]

  • 6. Curcumin Attenuates Retinal Vascular Leakage by Inhibiting Calcium/Calmodulin-Dependent Protein Kinase II Activity in Streptozotocin-Induced Diabetes.
    Li J, Wang P, Ying J, Chen Z, Yu S.
    Cell Physiol Biochem; 2016 May 15; 39(3):1196-208. PubMed ID: 27595397
    [Abstract] [Full Text] [Related]

  • 7. New dual peroxisome proliferator activated receptor agonist-Saroglitazar in diabetic dyslipidemia and non-alcoholic fatty liver disease: integrated analysis of the real world evidence.
    Kaul U, Parmar D, Manjunath K, Shah M, Parmar K, Patil KP, Jaiswal A.
    Cardiovasc Diabetol; 2019 Jun 17; 18(1):80. PubMed ID: 31208414
    [Abstract] [Full Text] [Related]

  • 8. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model.
    Muranaka K, Yanagi Y, Tamaki Y, Usui T, Kubota N, Iriyama A, Terauchi Y, Kadowaki T, Araie M.
    Invest Ophthalmol Vis Sci; 2006 Oct 17; 47(10):4547-52. PubMed ID: 17003451
    [Abstract] [Full Text] [Related]

  • 9. Treatment with hydrogen sulfide alleviates streptozotocin-induced diabetic retinopathy in rats.
    Si YF, Wang J, Guan J, Zhou L, Sheng Y, Zhao J.
    Br J Pharmacol; 2013 Jun 17; 169(3):619-31. PubMed ID: 23488985
    [Abstract] [Full Text] [Related]

  • 10. Antiretroviral drug-induced endothelial dysfunction is improved by dual PPARα/γ stimulation in obesity.
    Kamau F, Strijdom H, Mwangi P, Blackhurst D, Imperial E, Salie R.
    Vascul Pharmacol; 2019 Oct 17; 121():106577. PubMed ID: 31284000
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K, Goto K, Jesmin S, Maeda S, Miyauchi T, Kaji Y, Oshika T, Hori S.
    Curr Eye Res; 2006 Jan 17; 31(1):79-89. PubMed ID: 16421022
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
    Qiu F, Meng T, Chen Q, Zhou K, Shao Y, Matlock G, Ma X, Wu W, Du Y, Wang X, Deng G, Ma JX, Xu Q.
    Mol Pharm; 2019 May 06; 16(5):1958-1970. PubMed ID: 30912953
    [Abstract] [Full Text] [Related]

  • 15. Effect of antioxidant N-acetylcysteine on diabetic retinopathy and expression of VEGF and ICAM-1 from retinal blood vessels of diabetic rats.
    Zhu Y, Zhang XL, Zhu BF, Ding YN.
    Mol Biol Rep; 2012 Apr 06; 39(4):3727-35. PubMed ID: 21952821
    [Abstract] [Full Text] [Related]

  • 16. Saroglitazar for the treatment of dyslipidemia in diabetic patients.
    Joshi SR.
    Expert Opin Pharmacother; 2015 Mar 06; 16(4):597-606. PubMed ID: 25674933
    [Abstract] [Full Text] [Related]

  • 17. The ethanol extract of Zingiber zerumbet rhizomes mitigates vascular lesions in the diabetic retina.
    Hong TY, Tzeng TF, Liou SS, Liu IM.
    Vascul Pharmacol; 2016 Jan 06; 76():18-27. PubMed ID: 26319672
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.